Paul J Clancy
CIK 1409601 · EVP, Chief Financial Officer · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BIIB price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WILMINGTON, DE 19803
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 25,838 | $113.07 | $2.92M | -$1.42M | 45 | 2026-10-02 |
| SION | Director | — | $3.89 | — | $0 | 2 | 2026-06-18 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 0 | $104.91 | $0 | $0 | 8 | 2026-03-23 |
| XLO | Director | — | $8.55 | — | $0 | 5 | 2025-06-12 |
| AGIO | Director | 6,549 | $31.32 | $205.1K | $0 | 12 | 2022-06-23 |
| BIIB | Executive VP and CFO | 10,813 | $232.65 | $2.52M | -$48.55M | 55 | 2017-04-27 |
Recent Filings · Page 5 of 14
136 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-04 | INCY | Grant (A) | +343 | $25.2K | EDGAR |
| 2021-10-26 | XLO | Grant (A) | — | $0 | EDGAR |
| 2021-10-04 | INCY | Grant (A) | +321 | $22.1K | EDGAR |
| 2021-07-02 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,567 | $0 | EDGAR |
| 2021-07-02 | INCY | Grant (A) | +283 | $23.8K | EDGAR |
| 2021-06-02 | AGIO | Exer (M) | +1,686 | $0 | EDGAR |
| 2021-05-28 | INCY | Grant (A) | +1,923 | $0 | EDGAR |
| 2021-05-24 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2021-04-01 | INCY | Grant (A) | +298 | $24.2K | EDGAR |
| 2021-03-19 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,929 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.